Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)
3 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
Schedule of Anti-Dilutive Securities Excluded from Computation of Diluted Earnings per Share
Securities that were anti-dilutive and therefore excluded from the computation of diluted net loss per share were as follows:
Three Months Ended
  March 31,
  2023 2022
(in thousands)
Options to purchase common stock 240,081  326,300 
Non-vested RSUs and PSUs 2,431,316  2,641,362 
Convertible Notes 11,470,645  9,898,549 
Warrants —  470,000 
Total anti-dilutive securities 14,142,042  13,336,211